Therapeutical features of the facial cutaneous fistula

Authors

  • José Manuel Díaz Fernández Hospital Docente "Saturnino Lora". Instituto Superior de Ciencias Médicas, Santiago de Cuba

Keywords:

cutaneous fistula, surgery, facial dermatoses, penicillins, therapeutic use, cephalosporins, erytromicin, nalidixic acid.

Abstract

A cross-sectional study was carried out along 5 years (1984-1988), in which 99 patients with facial cutaneous fistulas were treated in the maxillofacial surgery service of the "Saturnino Lora" Educational Hospital, at Santiago de Cuba. It was confirmed that in order to establish favorable therapeutical prognosis in this entity, the treatment of the acute fistulas must be oriented towards eradicating or minimizing the acute phase by antimicrobial drug therapy of the kind of beta-lactam antibiotics, combined with the elimination of causal factors, followed in a mediate phase by fistulaplasty, in accordance with the individual requirements of each lesion. As for the chronic course lesions, the conduct must be directed towards the elimination of the causal agent, and exeresis of the fistulous section with a plasty of the affected area in the same surgical time, combined with prophylactic antibiotic therapy according to the bacteriological results. It is concluded that the postoperative evolution of this affection is significantly satisfactory, and the affections with an osteomyelitic origin have the highest complications incidence.

Downloads

Download data is not yet available.

Downloads

Published

1996-05-03

How to Cite

1.
Díaz Fernández JM. Therapeutical features of the facial cutaneous fistula. Rev Cubana Estomatol [Internet]. 1996 May 3 [cited 2025 Mar. 14];33(1):17-22. Available from: https://revestomatologia.sld.cu/index.php/est/article/view/2853

Issue

Vol. 33 No. 1 (1996): JAN- APR

Section

Research Article

License

Authors retain all rights to their works, which they can reproduce and distribute as long as they cite the primary source of publication.

The Rev Cubana Estomatol is subject to the Creative Commons Attribution-Non-Commercial 4.0 International License (CC BY-NC 4.0) and follows the publication model of SciELO Publishing Schema (SciELO PS) for publication in XML format.

You are free to:

  • Share — copy and redistribute the material in any medium or format.
  • Adapt — remix, transform, and build upon the material.

The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

  • You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
  • No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.